SEOUL, South Korea, July 3, 2024 /PRNewswire/ -- In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International City on July 3rd. The ceremony, commencing at 11 AM, marked a pivotal moment in the company's trajectory towards becoming a global top 10 Contract Development and Manufacturing Organization (CDMO).
Lotte Biologics and Merck Sign Letter of Intent (LOI) for Strategic Partnership
LOTTE BIOLOGICS Made a Notable Mark at the CPhI Japan 2024 Conference
LOTTE BIOLOGICS has been honored at the 2024 KSBB Spring Meeting
The Regulatory Innovation Meeting for Support of Biopharmaceutical CDMOs
LOTTE BIOLOGICS Signs an Agreement with Syracuse University
LOTTE BIOLOGICS Participates in `2024 DCAT Week`, Exploring Global Business
LOTTE BIOLOGICS Reveals Triple Digit Hiring Plan for 2024
LOTTE BIOLOGICS awarded Grand Prize at 6th Republic of Korea Job Creation Awards
LOTTE BIOLOGICS Signs Strategic Business Agreement with NJ Bio